| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | -0.12 | 0.002 |
| mRNA | VNLG/124 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.002 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | 0.36 | 0.003 |
| mRNA | selumetinib:UNC0638 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.13 | 0.003 |
| mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | -0.14 | 0.003 |
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.003 |
| mRNA | AT7867 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.003 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | 0.17 | 0.003 |
| mRNA | BRD-K09587429 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.003 |
| mRNA | YK 4-279 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.003 |